The UC Davis Comprehensive Cancer Center will retain its elite designation after being recognized by the National Cancer Institute as one of the nation's top cancer centers.
Only 51 centers nationwide currently hold NCI's "comprehensive" designation, which is awarded following a rigorous peer-review process that requires each center to provide evidence of collaboration and leadership as well as demonstrate high-quality programs in research, clinical care, education and community outreach.
"We are a critical cornerstone in the region's fight against cancer and this award signifies we meet the highest standards of excellence in oncology research, diagnostics and treatment," said UC Davis Health CEO Dr. David Lubarsky in a news release.
Along with the designation, the cancer center is being awarded a $17.5 million grant from the National Cancer Institute over five years to support the facility's research, care for patients, education, community outreach and engagement programs.
Some of the ongoing programs that will benefit from the funding are focused on addressing cancer disparities and reducing the cancer burden in underserved communities. The UC Davis Comprehensive Cancer Center is the only NCI-designated center serving the Central Valley and inland Northern California.
"The rapid pace of discovery and improved cancer treatments at NCI-designated cancer centers such as ours are increasing cancer survivorship and improving the quality of life for patients in our region," said Dr. Primo Lara Jr., director of the UC Davis Comprehensive Cancer Center, in a news release.
The cancer center first received the "comprehensive" designation in 2012. It serves more than 100,000 adults and children per year and conducts more than 200 active clinical trials at any one time.
